Shire Adderall XR Sales Suspended In Canada; FDA Stands By “Black Box”

Differences between FDA and Health Canada's regulatory responses to adverse event reports for Adderall XR are likely to raise more questions about FDA's drug safety review process

More from Archive

More from Pink Sheet